How to buy Abeona Therapeutics stock

Abeona Therapeutics Inc is a biotechnology business based in the US. Abeona Therapeutics shares (ABEO) are listed on the NASDAQ and all prices are listed in US Dollars. Abeona Therapeutics employs 88 staff and has a trailing 12-month revenue of around USD$7 million.

How to buy shares in Abeona Therapeutics

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Abeona Therapeutics. Find the stock by name or ticker symbol: ABEO. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Abeona Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Abeona Therapeutics, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Abeona Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced investors

Webull

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active investors. We picked Webull for this category because its platform offers features that cater to advancing investors as well as beginners. The desktop app is outfitted with an extensive set of research tools, the mobile app gets high grades from users and traders can test strategies with a paper-trading feature.

What's in this guide?

1. ABEO shares summary
2. Compare share dealing platforms
3. Is ABEO stock a buy or sell?
4. Stock performance over time
5. Can I short ABEO shares?
6. Abeona Therapeutics's financials
7. How volatile are ABEO shares?
8. Does Abeona Therapeutics pay a dividend?
9. Have ABEO shares ever split?
10. Other common questions

Abeona Therapeutics share price

Use our graph to track the performance of ABEO stocks over time.

Abeona Therapeutics shares at a glance

• Key figures

Information last updated 2021-03-02.

52-week range	USD$0.9895 - USD$3.79
50-day moving average	USD$2.3636
200-day moving average	USD$1.7949
Wall St. target price	USD$5.67
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.586

Buy Abeona Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Webull		$0	Stocks, Options, ETFs	$0	0%	Get two free stock valued between $2.50 and $250 Open an account	Margin financing rates start at 3.99%. No monthly subscription fees for margin.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Abeona Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Abeona Therapeutics Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Abeona Therapeutics shares

There are currently 3.0 million Abeona Therapeutics shares held short by investors – that's known as Abeona Therapeutics's "short interest". This figure is 2.6% up from 2.9 million last month.

There are a few different ways that this level of interest in shorting Abeona Therapeutics shares can be evaluated.

Abeona Therapeutics's "short interest ratio" (SIR)

Abeona Therapeutics's "short interest ratio" (SIR) is the quantity of Abeona Therapeutics shares currently shorted divided by the average quantity of Abeona Therapeutics shares traded daily (recently around 5.4 million). Abeona Therapeutics's SIR currently stands at 0.55. In other words for every 100,000 Abeona Therapeutics shares traded daily on the market, roughly 550 shares are currently held short.

However Abeona Therapeutics's short interest can also be evaluated against the total number of Abeona Therapeutics shares, or, against the total number of tradable Abeona Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Abeona Therapeutics's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Abeona Therapeutics shares in existence, roughly 30 shares are currently held short) or 0.0361% of the tradable shares (for every 100,000 tradable Abeona Therapeutics shares, roughly 36 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Abeona Therapeutics.

Find out more about how you can short Abeona Therapeutics stock.

Have Abeona Therapeutics's shares ever split?

Abeona Therapeutics's shares were split on a 1:50 basis on 24 October 2014. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Abeona Therapeutics shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Abeona Therapeutics shares which in turn could have impacted Abeona Therapeutics's share price.

Abeona Therapeutics share price volatility

Over the last 12 months, Abeona Therapeutics's shares have ranged in value from as little as $0.9895 up to $3.79. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abeona Therapeutics's is 1.5293. This would suggest that Abeona Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Abeona Therapeutics overview

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten disease; ABO-401 for the treatment of cystic fibrosis; and ABO-5OX for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. Abeona Therapeutics Inc. has a license agreement with REGENXBIO Inc. for the development and commercialization of gene therapies for the treatment of MPS IIIA, MPS IIIB, CLN1 disease, and CLN3 disease. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.

Frequently asked questions

• What percentage of Abeona Therapeutics is owned by insiders or institutions?

  Currently 16.219% of Abeona Therapeutics shares are held by insiders and 37.927% by institutions.

• How many people work for Abeona Therapeutics?

  Latest data suggests 88 work at Abeona Therapeutics.

• When does the fiscal year end for Abeona Therapeutics?

  Abeona Therapeutics's fiscal year ends in December.

• Where is Abeona Therapeutics based?

  Abeona Therapeutics's address is: 1330 Avenue of the Americas, New York, NY, United States, 10019

• What is Abeona Therapeutics's ISIN number?

  Abeona Therapeutics's international securities identification number is: US00289Y1073

• What is Abeona Therapeutics's CUSIP number?

  Abeona Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00289Y107